Will unlocking the secrets of the microbiome yield a promising new horizon for medicine?

How can machine learning techniques improve chemists ability to predict how hypothetical reactions might proceed?

John Fowler, COO at Piramal Pharma Solutions, discusses the challenges CDMOs face in manufacturing ADCs.

How to manufacture your API in the right quantity, at the right cost, and in the right time frame.

A recent study shows the capacity of anti-VEGFs to enter human breast milk.

Rethinking our approach to the use of energy and resources could help transform our relationship with the environment.

Higher productivity, lower hold times, lower costs… continuous processing for monoclonal antibodies could offer a number of advantages.

We only have one planet. We must play a responsible role when it comes to its care.

Can’t offer an “affordable” price? Then say goodbye to market exclusivity.

Industry experts share how their therapeutic products are shaping the future of the pharmaceutical landscape.